Media room

This section features official updates, announcements, press releases, and key highlights from our brand. Stay informed about company milestones, partnerships, and important media coverage.

Two bottles of water on a table at beach club

Gray Whale Vodka Launch: Ocean-Inspired Spirit Meets Conservation

Gray Whale, the coastal-inspired spirits brand, is making waves with its entry into the vodka market while simultaneously deepening its environmental commitments through a strategic partnership with the Surfrider Foundation. The dual announcement signals the brand’s evolution from gin specialist to a comprehensive lifestyle brand rooted in ocean stewardship.

Gray Whale Vodka Launch: Ocean-Inspired Spirit Meets Conservation Read More »

Yellow cube with risk meter on keyboard

Small Business Optimism Hits Historic Low as Costs Soar

The NFIB Small Business Optimism Index has plummeted to 95.8 in March, marking a troubling departure from the historical average of 98.0 and signaling deepening economic headwinds for entrepreneurs. Rising input costs, supply chain chaos, and surging uncertainty are forcing small business owners to make difficult decisions about pricing, hiring, and capital investment.

Small Business Optimism Hits Historic Low as Costs Soar Read More »

a close up of a black surface with white letters

China Blocks Meta’s $2 Billion Manus AI Acquisition

Chinese authorities have moved to block Meta’s ambitious $2 billion acquisition of artificial intelligence startup Manus, marking a significant setback for the tech giant’s expansion plans. The decision comes after an extended period of regulatory examination that underscores Beijing’s increasingly cautious stance toward major tech acquisitions.

China Blocks Meta’s $2 Billion Manus AI Acquisition Read More »

a screen shot of a stock chart on a computer

Gossamer Bio Hit With Securities Lawsuit After Trial Collapse

Gossamer Bio, Inc. has become the target of a securities class action lawsuit filed by investors who suffered significant losses following the company’s Phase 3 PROSERA trial failure. The biotech firm’s stock plummeted approximately 80% during the class period, triggering investor claims of material misrepresentation and omission.

Gossamer Bio Hit With Securities Lawsuit After Trial Collapse Read More »